Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AgfiledCriticalNovartis Ag
Priority to CU20100214ApriorityCriticalpatent/CU20100214A7/en
Publication of CU20100214A7publicationCriticalpatent/CU20100214A7/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La invención se refiere a novedosos compuestos orgánicos de la fórmula (I): ESPACIO PARA LA FÓRMULA a procesos para su preparación, a su aplicación en un proceso para el tratamiento del cuerpo humano o animal, a su uso -solos o en combinación con uno o más compuestos farmacéuticamente activos diferentes- para el tratamiento de una enfermedad inflamatoria u obstructiva de las vías respiratorias, tal como asma, trastornos que se presentan comúnmente en relación con trasplante, o una enfermedad proliferativa, tal como una enfermedad tumoral.The invention relates to novel organic compounds of the formula (I): SPACE FOR THE FORMULA to processes for its preparation, to its application in a process for the treatment of the human or animal body, to its use - alone or in combination with one or more different pharmaceutically active compounds - for the treatment of an inflammatory or obstructive airway disease, such as asthma, disorders that commonly occur in relation to transplantation, or a proliferative disease, such as a tumor disease.
CU20100214A2010-10-292010-10-29
IMIDAZOQUINOLINAS AS LIPID KINASE INHIBITORS
CU20100214A7
(en)
Compounds derived from heteroaryloxy amides of substituted benzoic acid, p38 map kinase inhibitors; compound preparation process; pharmaceutical composition; procedure for preparing said composition; and use in the treatment of airway diseases such as epoc and asthma.
Compounds derived from phenylamino-isonicotinamide; mek inhibitors; Pharmaceutical composition and use for the treatment of hyperproliferative diseases such as cancer and inflammation.